1-855-378-42281-855-378-4228
One of the out-patient rehabilitation options for people in Frankfort struggling with opioid abuse and addiction is opioid maintenance therapy. Some centers and doctors are certified to dispense specific medications to opioid dependent people, many that are opioid-based themselves and are habit forming. With low doses however, the individual does not experience high feelings and also doesn't have intense cravings and is not experiencing opioid withdrawal. Methadone is the first drug used for this reason, but there are alternative choices currently to select from.
Methadone is an opiate and is meant to be taken at an outpatient clinic licensed to dispense the drug, which is taken daily as a pill or liquid. The price of the drug is about $150 a month. Buprenorphine is also an opiate based med, and is in pill form often taken one day on, one day off. But unlike Methadone which is only be given in highly structured medical centers, Buprenorphine can be and is prescribed and administered in doctor's offices. The cost monthly of buprenorphine is approximately three hundred dollars per month for the generic version of the medication. There is also a version of buprenorphine that contains naloxone, which is a med which blocks the effects of opioids. An individual taking this formulation, also known as Suboxone, would find it more difficult to get high from opioids if they relapsed while taking the drug. It too is taken on a daily basis, and is priced around $450 /month. Naltrexone is an additional drug taken in opioid maintenance therapy, but unlike the other medications mentioned it is an opioid blocker and isn't an opioid. There is an option to take this medication as a monthly injection, which is called Vivitrol. As an opioid blocker, the drug prevents an individual from getting high from opioids, and therefore lowers the risk associated with relapse. This daily injection costs anywhere from $1000 to $1200 per month.
For All Alcohol and Drug Rehabilitation Programs In Frankfort, Click Here.
